Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
Journal of Leukocyte Biology, 09/11/09
Ehrchen JM et al. – This proinflammatory action of S100A8/S100A9 involves autocrine and paracrine mechanisms in phagocytes, endothelium, and other cells. As a net result, extravasation of leukocytes into inflamed tissues and their subsequent activation are increased. Thus, S100A8/S100A9 plays a pivotal role during amplification of inflammation and represents a promising new therapeutic target.
Related Articles
Obesity linked to specific cancers
Internet Source, 11/05/09
Relevance Score: 97%
Screening for Cancer
MedLinePlus, 11/02/09
Relevance Score: 97%
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 97%
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 97%
Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09
Relevance Score: 97%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
CCR1-mediated activation of nuclear factor-B in THP-1 monocytic cells involves pertussis toxin-insensitive G14 and G16 signaling cascades
Journal of Leukocyte Biology, 12/18/09
IgE signaling suppresses Fc[epsilon]RI[beta] expression
Journal of Leukocyte Biology, 12/18/09
The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils
Journal of Leukocyte Biology, 12/18/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Can antigen-specific regulatory T cells protect against graft vs. host disease and spare anti-malignancy alloresponse
Haematologica, 12/18/09
Mutiny on the Boun-T: Controlling Dangerous T Cells Through Anergy
Discovery Medicine, 12/17/09
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Breast Cancer Research and Treatment, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


